Plus Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Marc H. Hedrick, with a market cap of $45.4M.
Based on Q1 2026 filing
Common questions about Plus Therapeutics
Plus Therapeutics (PSTV) has a market capitalization of $45.4M and trades on NASDAQ.
Plus Therapeutics has approximately 20 employees.